The role of ATG in reducing acute GvHD in related and unrelated donor transplants

被引：0
|
作者：
Zalyalov, Y [1 ]
Ganapiev, A [1 ]
Alexeev, S [1 ]
Smirnova, A [1 ]
Stancheva, N [1 ]
Ivanova, N [1 ]
Alyanskiy, A [1 ]
Afanasyev, B [1 ]
机构：
[1] Pavlovs State Med Univ, St Petersburg, Russia
来源：
BONE MARROW TRANSPLANTATION | 2006年 / 37卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S314 / S314
页数：1
相关论文
共 50 条
  • [1] The role of ATG in reducing acute GvHD and primary graft rejection in related and unrelated donor transplants
    Zalyalov, Y.
    Ganapiev, B.
    Ivanova, N.
    Alyanskiy, A.
    Afanasyev, B.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S120 - S120
  • [2] Low rates of acute and chronic GVHD with ATG and PTCy in matched and mismatched unrelated donor peripheral blood stem cell transplants
    Prem, Shruti
    Atenafu, Eshetu G.
    Al-Shaibani, Zeyad
    Loach, David
    Law, Arjun
    Lam, Wilson
    Michelis, Fotios V.
    Thyagu, Santhosh
    Kim, Dennis
    Lipton, Jeffrey Howard
    Kumar, Rajat
    Viswabandya, Auro
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2019, 102 (06) : 486 - 493
  • [3] Low early doses of ATG are effective in GVHD prevention in unrelated myeloablative stem cell transplants for acute leukemia and myelodysplasia
    Bonifazi, F.
    Olivieri, J.
    Sessa, M.
    Dan, E.
    Sinigaglia, B.
    Papayannidis, C.
    Paolini, S.
    Rizzi, S.
    Motta, M. Rosa
    Pedone, C.
    Bontadini, A.
    Martinelli, G.
    Cavo, M.
    Arpinati, M.
    Bandini, G.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S224 - S224
  • [4] Long term follow up of two randomized trials on antithymocyte globulin (ATG) for GvHD prophylaxis in unrelated donor transplants: Chronic GvHD, bronchiolitis and quality of life
    Bacigalupo, A
    Vignola, M
    Lamparelli, T
    Bruzzi, P
    Guidi, S
    Alessandrino, P
    Di Bartolomeo, P
    Oneto, R
    Bruno, B
    Barbanti, M
    Sacchi, N
    Van Lint, MT
    Bosi, A
    BLOOD, 2004, 104 (11) : 128A - 128A
  • [5] Tacrolimus and mycophenolate mofetil for GVHD prevention after unrelated donor transplants.
    McSweeney, P
    Abhyankar, S
    Petersen, F
    Devetten, M
    Arcaroli, J
    Zeng, C
    Baron, A
    Hardiman, P
    McGuirk, J
    Bearman, S
    Nieto, Y
    Foran, J
    Pulsipher, M
    Pavletic, S
    BLOOD, 2003, 102 (11) : 717A - 717A
  • [6] Haploidentical related transplants and unrelated donor transplants with T cell addback
    Veys, PA
    Meral, A
    Hassan, A
    Goulden, N
    Webb, D
    Davies, G
    BONE MARROW TRANSPLANTATION, 1998, 21 : S42 - S44
  • [7] Recent decrease in acute GVHD and increased relapse in children with leukemia receiving unrelated donor bone marrow transplants
    Davies, Stella M.
    Wang, D.
    Wang, T.
    Arora, A.
    Ringden, O.
    Anasetti, C.
    Pavletic, S.
    Casper, J.
    MacMillan, M. L.
    Sanders, J.
    Wall, D.
    Kernan, N. A.
    BLOOD, 2007, 110 (11) : 327A - 328A
  • [8] The role of matched unrelated donor transplants in the management of malignancy
    Apperley, JF
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 272 - 272
  • [9] Post-transplantation cyclophosphamide compared to GvHD prophylaxis with ATG in HCT with mismatched unrelated donor
    Soltermann, Yves
    Heim, Dominik
    Baldomero, Helen
    Medinger, Michael
    Halter, Jorg P.
    Passweg, Jakob R.
    Kleber, Martina
    SWISS MEDICAL WEEKLY, 2018, 148 : 6S - 7S
  • [10] Antithymocyte globulin (ATG) prevents severe acute graft versus host disease (GVHD) in unrelated donor transplants: two randomized studies from the Gruppo Italiano Trapianto Midollo Osseo (GITMO)
    Bacigalupo, A
    Bosi, A
    Bruzzi, P
    Lamparelli, T
    Gualandi, F
    Alessandrino, P
    Di Bartolomeo, P
    Berisso, G
    Bregante, S
    Raiola, A
    Di Gazia, C
    Dominietto, A
    Oneto, R
    Bruno, B
    van Lint, M
    BONE MARROW TRANSPLANTATION, 2001, 27 : S171 - S171
12345